ALT
Price
$6.23
Change
+$0.08 (+1.30%)
Updated
Oct 4 closing price
31 days until earnings call
INZY
Price
$5.17
Change
+$0.11 (+2.17%)
Updated
Oct 4 closing price
31 days until earnings call
Ad is loading...

ALT vs INZY

Header iconALT vs INZY Comparison
Open Charts ALT vs INZYBanner chart's image
Altimmune
Price$6.23
Change+$0.08 (+1.30%)
Volume$1.19M
CapitalizationN/A
Inozyme Pharma
Price$5.17
Change+$0.11 (+2.17%)
Volume$165.13K
CapitalizationN/A
View a ticker or compare two or three
ALT vs INZY Comparison Chart
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ALT vs. INZY commentary
Oct 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a Hold and INZY is a Hold.

COMPARISON
Comparison
Oct 06, 2024
Stock price -- (ALT: $6.23 vs. INZY: $5.17)
Brand notoriety: ALT and INZY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 50% vs. INZY: 64%
Market capitalization -- ALT: $459.83M vs. INZY: $347.57M
ALT [@Biotechnology] is valued at $459.83M. INZY’s [@Biotechnology] market capitalization is $347.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileINZY’s FA Score has 0 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • INZY’s FA Score: 0 green, 5 red.
According to our system of comparison, INZY is a better buy in the long-term than ALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 3 TA indicator(s) are bullish while INZY’s TA Score has 3 bullish TA indicator(s).

  • ALT’s TA Score: 3 bullish, 6 bearish.
  • INZY’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ALT is a better buy in the short-term than INZY.

Price Growth

ALT (@Biotechnology) experienced а -3.71% price change this week, while INZY (@Biotechnology) price change was -0.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +1.89%, and the average quarterly price growth was -5.77%.

Reported Earning Dates

ALT is expected to report earnings on Nov 05, 2024.

INZY is expected to report earnings on Nov 05, 2024.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALT($460M) has a higher market cap than INZY($348M). INZY YTD gains are higher at: 21.361 vs. ALT (-44.622). INZY has higher annual earnings (EBITDA): -82.82M vs. ALT (-100.91M). ALT has more cash in the bank: 165M vs. INZY (145M). ALT has less debt than INZY: ALT (1.86M) vs INZY (46.7M). ALT has higher revenues than INZY: ALT (409K) vs INZY (0).
ALTINZYALT / INZY
Capitalization460M348M132%
EBITDA-100.91M-82.82M122%
Gain YTD-44.62221.361-209%
P/E RatioN/AN/A-
Revenue409K0-
Total Cash165M145M114%
Total Debt1.86M46.7M4%
FUNDAMENTALS RATINGS
ALT: Fundamental Ratings
ALT
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
82
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALTINZY
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
85%
Bullish Trend 2 days ago
87%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
ALT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMJPX11.240.22
+2.00%
PIMCO RAE US Small I-2
LEAOX13.120.14
+1.08%
Lazard Emerging Markets Eq Advtg Open
JFCIX37.180.33
+0.90%
JHancock Fundamental All Cap Core I
TGIHX16.410.12
+0.74%
Nuveen Core Equity I
TRXAX11.810.01
+0.08%
Catalyst/MAP Global Balanced A

ALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with INZY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
+1.30%
INZY - ALT
44%
Loosely correlated
+2.17%
EDIT - ALT
43%
Loosely correlated
+5.63%
PLRX - ALT
43%
Loosely correlated
+3.69%
VKTX - ALT
43%
Loosely correlated
+1.33%
RCKT - ALT
42%
Loosely correlated
+2.18%
More

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
+2.17%
BEAM - INZY
59%
Loosely correlated
+2.05%
NTLA - INZY
55%
Loosely correlated
+1.93%
DNLI - INZY
51%
Loosely correlated
+1.45%
PLRX - INZY
51%
Loosely correlated
+3.69%
SEER - INZY
50%
Loosely correlated
+3.09%
More